Latest news

November 6, 2003

Debiopharm presents results of a first monthly injectable sustained-release fomulation of ZT-1 for Alzheimer´s Disease

October 23, 2003

Debiopharm and Tulane Cancer Center select Hemenway as the 2003 Mauvernay Research Excellence Scholar

October 20, 2003

Debiopharm SA starts a Phase II trial for a once daily oral formulation of ZT-1 to treat Alzheimer´s

July 29, 2003

Debiopharm S.A. and Dyax Corp. granted European Orphan Drug Status for EPI-hNE4 (DX-890) for Cystic Fibrosis Indication

July 24, 2003

H3 Pharma Inc. announces important step in bringing SANVAR® (vapreotide) to U.S. market

July 2, 2003

H3 Pharma Inc. Licenses in Sanvar ® (vapreotide) from Debiopharm S.A.

June 4, 2003

DEBIOPHARM S.A. licenses-in a compound from Genodyssee S.A.

January 16, 2003

Debiopharm S.A. provides funding to Tulane University

November 19, 2002

Debiopharm S.A. announces a patent application on a hydrosoluble prodrug of cyclosporin A

Stay informed